Related references
Note: Only part of the references are listed.Principles of N-Linked Glycosylation Variations of IgG-Based Therapeutics: Pharmacokinetic and Functional Considerations
Souad Boune et al.
ANTIBODIES (2020)
Physicochemical and functional assessments demonstrating analytical similarity between rituximab biosimilar HLX01 and the MabThera®
Yanpeng Xu et al.
MABS (2019)
Physicochemical and Biological Characterization of RTXM83, a New Rituximab Biosimilar
Maria L. Cerutti et al.
BIODRUGS (2019)
Assessment of structural and functional similarity of biosimilar products: Rituximab as a case study
Neh Nupur et al.
MABS (2018)
Therapeutic monoclonal antibody N-glycosylation Structure, function and therapeutic potential
Florian Cymer et al.
BIOLOGICALS (2018)
Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal product
Kyoung Hoon Lee et al.
MABS (2018)
Past, Present, and Future of Rituximab-The world's First Oncology Monoclonal Antibody Therapy
Timothy M. Pierpont et al.
FRONTIERS IN ONCOLOGY (2018)
Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab
Jyoti Velayudhan et al.
BIODRUGS (2016)
Effect of high mannose glycan pairing on IgG antibody clearance
Yaoqing Diana Liu et al.
BIOLOGICALS (2016)
N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins
Fabian Higel et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodies
Marco Thomann et al.
MOLECULAR IMMUNOLOGY (2016)
N-glycosylation profile analysis of Trastuzumab biosimilar candidates by Normal Phase Liquid Chromatography and MALDI-TOF MS approaches
Ivan Sanchez-De Melo et al.
JOURNAL OF PROTEOMICS (2015)
ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
Tauno Metsalu et al.
NUCLEIC ACIDS RESEARCH (2015)
Pharmacokinetic Comparability of a Biosimilar Trastuzumab Anticipated from Its Physicochemical and Biological Characterization
Mariana P. Miranda-Hernandez et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Target-directed development and preclinical characterization of the proposed biosimilar rituximab GP2013
Antonio da Silva et al.
LEUKEMIA & LYMPHOMA (2014)
Mass spectrometry-based analysis of glycoproteins and its clinical applications in cancer biomarker discovery
Huan Liu et al.
CLINICAL PROTEOMICS (2014)
Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques
Daniel Ayoub et al.
MABS (2013)
Analytical characterization of biosimilar antibodies and Fc-fusion proteins
Alain Beck et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2013)
Production, characterization and pharmacokinetic properties of antibodies with N-linked Mannose-5 glycans
Marcella Yu et al.
MABS (2012)
High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans
Andrew M. Goetze et al.
GLYCOBIOLOGY (2011)
Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding
Damian Houde et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Expression systems for therapeutic glycoprotein production
Yves Durocher et al.
CURRENT OPINION IN BIOTECHNOLOGY (2009)
Optimal and consistent protein glycosylation in mammalian cell culture
Patrick Hossler et al.
GLYCOBIOLOGY (2009)
Glycosylation as a strategy to improve antibody-based therapeutics
Roy Jefferis
NATURE REVIEWS DRUG DISCOVERY (2009)
Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion
Jun Qian et al.
ANALYTICAL BIOCHEMISTRY (2007)
Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types
Yutaka Kanda et al.
GLYCOBIOLOGY (2007)
Post-translational modifications in the context of therapeutic proteins
Gary Walsh et al.
NATURE BIOTECHNOLOGY (2006)
Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies
D Chelius et al.
ANALYTICAL CHEMISTRY (2006)
A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity
JS Lam et al.
JOURNAL OF IMMUNOLOGY (2005)
Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro
J Hodoniczky et al.
BIOTECHNOLOGY PROGRESS (2005)
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity
T Shinkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
